Mr. Marcos Agramont reports
ISODIOL INTERNATIONAL INC. ANNOUNCES CBD BEVERAGE EXPANSION PLANS THROUGH FLORIDA BASED SUBSIDIARY, ISOBEV
Isodiol International Inc.
has provided an update on its recently
Azure. The company is planning for increased warehousing capabilities and expansion of the production facility located in Leesburg, Fla.
is Isodiol International's division that focuses on growing its beverage brand portfolio and contract manufacturing services for the beverage industry. With the expansion of the Leesburg warehouse, Isodiol International will be able to facilitate its distribution needs in the southeast market and provide Azure additional space to increase production for its customers, which include
Isodiol International is also preparing to expand its beverage production capabilities for bottling in Leesburg to include a sparkling line and flavoured line to meet the increased demands for functional beverages that include cannabidiol.
"Given the growing global awareness of CBD and the company's belief that the 2018 Farm Bill is bound to pass in the United States, which will also bring clarity to the legality of hemp-derived CBD, we believe the expansion of our Florida bottling facility positions the company to further capitalize on this emerging segment of the beverage industry," commented Marcos Agramont, Isodiol International's chief executive officer. "This expansion will increase our bottling capabilities and expand our product offerings to our sales channel partners."
About Isodiol International Inc.
Isodiol International is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions that is focused on the nutritional health benefits that are derived from hemp.
Isodiol International has commercialized a 99-per-cent-plus-pure, naturally isolated cannabidiol, including microencapsulations, and nanotechnology for quality consumable and topical skin care products. Most recently, the company received approval for its cannabidiol designated as an active pharmaceutical ingredient for use in finished pharmaceutical products, as was announced on
April 26, 2018.
Isodiol International's growth strategy includes the development of over-the-counter and pharmaceutical drugs, as well as continued international expansion into Latin America, Asia and Europe.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.